Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-02-13 Sale |
2023-02-15 5:11 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
21,695 | $0.93 | $20,176 | 613,215 (Direct) |
View |
2022-08-17 Sale |
2022-08-19 1:08 pm |
X4 Pharmaceuticals Inc | XFOR | Meisner Derek M Chief Legal Officer |
8,334 | $0 | $0 | 145,155 (Direct) |
View |
2022-08-17 Sale |
2022-08-19 1:07 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
1,713 | $0 | $0 | 177,896 (Direct) |
View |
2022-08-17 Sale |
2022-08-19 1:05 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
13,448 | $0 | $0 | 634,910 (Direct) |
View |
2022-08-17 Sale |
2022-08-19 1:04 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
10,834 | $0 | $0 | 173,917 (Direct) |
View |
2022-06-30 Sale |
2022-07-01 5:01 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
2,641 | $0 | $0 | 184,751 (Direct) |
View |
2022-06-30 Sale |
2022-07-01 4:56 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
1,578 | $0 | $0 | 179,609 (Direct) |
View |
2022-06-24 Sale |
2022-06-27 4:14 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
5,416 | $0 | $0 | 187,392 (Direct) |
View |
2022-06-24 Sale |
2022-06-27 4:09 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
856 | $0 | $0 | 181,187 (Direct) |
View |
2022-06-24 Sale |
2022-06-27 4:09 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
6,724 | $0 | $0 | 648,358 (Direct) |
View |
2022-06-24 Sale |
2022-06-27 4:08 pm |
X4 Pharmaceuticals Inc | XFOR | Meisner Derek M Chief Legal Officer |
4,166 | $0 | $0 | 153,489 (Direct) |
View |
2022-06-16 Sale |
2022-06-17 4:22 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
5,416 | $0 | $0 | 192,808 (Direct) |
View |
2022-06-16 Sale |
2022-06-17 4:22 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
6,724 | $0 | $0 | 655,082 (Direct) |
View |
2022-06-16 Sale |
2022-06-17 4:21 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
856 | $0 | $0 | 182,043 (Direct) |
View |
2022-06-16 Sale |
2022-06-17 4:21 pm |
X4 Pharmaceuticals Inc | XFOR | Meisner Derek M Chief Legal Officer |
4,166 | $0 | $0 | 157,655 (Direct) |
View |
2022-06-03 Sale |
2022-06-06 4:14 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
6,292 | $1.21 | $7,613 | 661,806 (Direct) |
View |
2022-02-11 Sale |
2022-02-14 4:23 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
27,721 | $0 | $0 | 93,224 (Direct) |
View |
2022-02-11 Sale |
2022-02-14 4:22 pm |
X4 Pharmaceuticals Inc | XFOR | Meisner Derek M Chief Legal Officer |
15,909 | $0 | $0 | 56,821 (Direct) |
View |
2022-02-11 Sale |
2022-02-14 4:22 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
12,545 | $0 | $0 | 77,899 (Direct) |
View |
2022-02-11 Sale |
2022-02-14 4:20 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
21,695 | $0 | $0 | 447,309 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-11-07 Option Award |
2022-11-09 4:23 pm |
N/A 2032-11-07 |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
1,350,000 | $0 | 1,350,000 (Direct) |
View |
2022-11-07 Option Award |
2022-11-09 4:22 pm |
N/A 2032-11-07 |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
1,350,000 | $0 | 1,350,000 (Direct) |
View |
2022-11-07 Option Award |
2022-11-09 4:22 pm |
N/A 2032-11-07 |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
2022-11-07 Option Award |
2022-11-09 4:21 pm |
N/A 2032-11-07 |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
3,438,335 | $0 | 3,438,335 (Direct) |
View |
2022-11-03 Option Award |
2022-11-04 4:18 pm |
N/A 2032-11-03 |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
341,000 | $1.89 | 341,000 (Direct) |
View |
2022-06-06 Option Award |
2022-06-27 4:17 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Bridger Gary Director |
6,667 | $0 | 6,667 (Direct) |
View |
2022-06-06 Option Award |
2022-06-27 4:17 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
6,667 | $0 | 6,667 (Direct) |
View |
2022-06-06 Option Award |
2022-06-27 4:16 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | WYZGA MICHAEL S Director |
6,667 | $0 | 6,667 (Direct) |
View |
2022-06-06 Option Award |
2022-06-27 4:16 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | de Craecker Francoise Director |
6,667 | $0 | 6,667 (Direct) |
View |
2022-06-06 Option Award |
2022-06-27 4:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Stewart Murray Director |
6,667 | $0 | 6,667 (Direct) |
View |
2022-06-06 Option Award |
2022-06-27 4:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Aliski William Director |
6,667 | $0 | 6,667 (Direct) |
View |
2022-06-06 Option Award |
2022-06-27 4:10 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | MCGIRR DAVID W J Director |
6,667 | $0 | 6,667 (Direct) |
View |
2022-03-01 Option Award |
2022-03-01 4:16 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
105,000 | $0 | 182,899 (Direct) |
View |
2022-03-01 Option Award |
2022-03-01 4:16 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
220,789 | $0 | 668,098 (Direct) |
View |
2022-03-01 Option Award |
2022-03-01 4:09 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
97,000 | $0 | 104,107 (Direct) |
View |
2022-03-01 Option Award |
2022-03-01 4:09 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
105,000 | $0 | 198,224 (Direct) |
View |
2022-03-01 Option Award |
2022-03-01 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer |
97,000 | $0 | 104,107 (Direct) |
View |
2022-03-01 Option Award |
2022-03-01 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Meisner Derek M Chief Legal Officer |
105,000 | $0 | 161,821 (Direct) |
View |
2022-02-11 Tax Withholding |
2022-02-14 4:21 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
928 | $0 | 7,107 (Direct) |
View |